{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:33:53Z","timestamp":1793644433302,"version":"4.5.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the First Affiliated Hospital of Gannan Medical University, Doctor Start-up Fund","award":["QD088"],"award-info":[{"award-number":["QD088"]}],"id":[{"id":"https:\/\/ror.org\/040gnq226","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32360216"],"award-info":[{"award-number":["32360216"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04303-8","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T14:24:18Z","timestamp":1745159058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and safety of mesenchymal stem cell therapy in acute on chronic liver failure: a systematic review and meta-analysis of randomized controlled clinical trials"],"prefix":"10.1186","volume":"16","author":[{"given":"Wenming","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingkun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lincai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1958-5286","authenticated-orcid":false,"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,20]]},"reference":[{"issue":"3","key":"4303_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","volume":"66","author":"R Hernaez","year":"2017","unstructured":"Hernaez R, Sol\u00e0 E, Moreau R, Gin\u00e8s P. Acute-on-chronic liver failure: an update. Gut. 2017;66(3):541\u201353.","journal-title":"Gut"},{"issue":"2","key":"4303_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3748\/wjg.v29.i2.232","volume":"29","author":"NLY Ngu","year":"2023","unstructured":"Ngu NLY, Flanagan E, Bell S, Le ST. Acute-on-chronic liver failure: controversies and consensus. World J Gastroenterol. 2023;29(2):232\u201340.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"4303_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/ueg2.12482","volume":"11","author":"M Morrison","year":"2023","unstructured":"Morrison M, Artru F. Predicting the development of acute-on-chronic liver failure. United Eur Gastroenterol J. 2023;11(9):813\u20134.","journal-title":"United Eur Gastroenterol J"},{"issue":"7","key":"4303_CR4","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426\u201337, 1437.e1421-1429.","journal-title":"Gastroenterology"},{"issue":"5","key":"4303_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ajt.2024.02.001","volume":"24","author":"F Artru","year":"2024","unstructured":"Artru F, McPhail MJ. Immunopathogenesis of acute on chronic liver failure. Am J Transpl. 2024;24(5):724\u201332.","journal-title":"Am J Transpl"},{"issue":"3","key":"4303_CR6","doi-asserted-by":"publisher","first-page":"e25791","DOI":"10.1016\/j.heliyon.2024.e25791","volume":"10","author":"CZ Bai","year":"2024","unstructured":"Bai CZ, Ren J, Zhang X, Hu YY, Wang XP, Tang XW, Tang SH. Global acute-on-chronic liver failure trends during 2012\u20132022: a bibliometric study. Heliyon. 2024;10(3):e25791.","journal-title":"Heliyon"},{"key":"4303_CR7","doi-asserted-by":"publisher","first-page":"10108","DOI":"10.3389\/ti.2022.10108","volume":"35","author":"MS Schulz","year":"2022","unstructured":"Schulz MS, Gu W, Schnitzbauer AA, Trebicka J. Liver transplantation as a cornerstone treatment for acute-on-chronic liver failure. Transpl Int. 2022;35:10108.","journal-title":"Transpl Int"},{"key":"4303_CR8","doi-asserted-by":"publisher","first-page":"935160","DOI":"10.3389\/fimmu.2022.935160","volume":"13","author":"R Qiang","year":"2022","unstructured":"Qiang R, Liu XZ, Xu JC. The immune pathogenesis of acute-on-chronic liver failure and the danger hypothesis. Front Immunol. 2022;13:935160.","journal-title":"Front Immunol"},{"issue":"3","key":"4303_CR9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3350\/cmh.2022.0103","volume":"29","author":"VK Br","year":"2023","unstructured":"Br VK, Sarin SK. Acute-on-chronic liver failure: terminology, mechanisms and management. Clin Mol Hepatol. 2023;29(3):670\u201389.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"4303_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/lt.25678","volume":"26","author":"G Cullaro","year":"2020","unstructured":"Cullaro G, Sharma R, Trebicka J, C\u00e1rdenas A, Verna EC. Precipitants of acute-on-chronic liver failure: an opportunity for preventative measures to improve outcomes. Liver Transpl. 2020;26(2):283\u201393.","journal-title":"Liver Transpl"},{"issue":"5","key":"4303_CR11","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","volume":"66","author":"J Wendon","year":"2017","unstructured":"Wendon J, Cordoba J, Dhawan A, Larsen FS, Manns M, Samuel D, Simpson KJ, Yaron I, Bernardi M. EASL clinical practical guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66(5):1047\u201381.","journal-title":"J Hepatol"},{"issue":"2","key":"4303_CR12","first-page":"225","volume":"117","author":"JS Bajaj","year":"2022","unstructured":"Bajaj JS, O\u2019Leary JG, Lai JC, Wong F, Long MD, Wong RJ, Kamath PS. Acute-on-chronic liver failure clinical guidelines. Am J Gastroenterol. 2022;117(2):225\u201352.","journal-title":"Am J Gastroenterol"},{"key":"4303_CR13","doi-asserted-by":"crossref","unstructured":"Buti M, Ruiz-Cobo JC, Esteban R, Riveiro-Barciela M. Hepatitis E as a trigger for acute-on-chronic liver failure. Clin Mol Hepatol. 2025;31(Suppl):S196\u2013s204.","DOI":"10.3350\/cmh.2024.0758"},{"issue":"1","key":"4303_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13613-017-0249-6","volume":"7","author":"D Weil","year":"2017","unstructured":"Weil D, Levesque E, McPhail M, Cavallazzi R, Theocharidou E, Cholongitas E, et al. Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis. Ann Intensive Care. 2017;7(1):33.","journal-title":"Ann Intensive Care"},{"issue":"7","key":"4303_CR15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/17474124.2022.2097070","volume":"16","author":"N Abbas","year":"2022","unstructured":"Abbas N, Rajoriya N, Elsharkawy AM, Chauhan A. Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived? Expert Rev Gastroenterol Hepatol. 2022;16(7):639\u201352.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"4303_CR16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S2468-1253(23)00363-1","volume":"9","author":"F Artru","year":"2024","unstructured":"Artru F, Trovato F, Morrison M, Bernal W, McPhail M. Liver transplantation for acute-on-chronic liver failure. Lancet Gastroenterol Hepatol. 2024;9(6):564\u201376.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"42","key":"4303_CR17","doi-asserted-by":"publisher","first-page":"12125","DOI":"10.3748\/wjg.v21.i42.12125","volume":"21","author":"S Blasco-Algora","year":"2015","unstructured":"Blasco-Algora S, Masegosa-Ataz J, Guti\u00e9rrez-Garc\u00eda ML, Alonso-L\u00f3pez S, Fern\u00e1ndez-Rodr\u00edguez CM. Acute-on-chronic liver failure: pathogenesis, prognostic factors and management. World J Gastroenterol. 2015;21(42):12125\u201340.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4303_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13287-018-0814-4","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Li Y, Zhang L, Li J, Zhu C. Mesenchymal stem cells: potential application for the treatment of hepatic cirrhosis. Stem Cell Res Ther. 2018;9(1):59.","journal-title":"Stem Cell Res Ther"},{"issue":"38","key":"4303_CR19","doi-asserted-by":"publisher","first-page":"14051","DOI":"10.3748\/wjg.v20.i38.14051","volume":"20","author":"XN Pan","year":"2014","unstructured":"Pan XN, Zheng LQ, Lai XH. Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis. World J Gastroenterol. 2014;20(38):14051\u20137.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4303_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13287-021-02138-7","volume":"12","author":"Y Tang","year":"2021","unstructured":"Tang Y, Zhou Y, Li HJ. Advances in mesenchymal stem cell exosomes: a review. Stem Cell Res Ther. 2021;12(1):71.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4303_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s13287-022-03054-0","volume":"13","author":"R Margiana","year":"2022","unstructured":"Margiana R, Markov A, Zekiy AO, Hamza MU, Al-Dabbagh KA, Al-Zubaidi SH, et al. Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review. Stem Cell Res Ther. 2022;13(1):366.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"4303_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00018-022-04207-3","volume":"79","author":"F Velarde","year":"2022","unstructured":"Velarde F, Ezquerra S, Delbruyere X, Caicedo A, Hidalgo Y, Khoury M. Mesenchymal stem cell-mediated transfer of mitochondria: mechanisms and functional impact. Cell Mol Life Sci. 2022;79(3):177.","journal-title":"Cell Mol Life Sci"},{"key":"4303_CR23","doi-asserted-by":"publisher","first-page":"728190","DOI":"10.3389\/fimmu.2021.728190","volume":"12","author":"A Li","year":"2021","unstructured":"Li A, Guo F, Pan Q, Chen S, Chen J, Liu HF, Pan Q. Mesenchymal stem cell therapy: hope for patients with systemic lupus erythematosus. Front Immunol. 2021;12:728190.","journal-title":"Front Immunol"},{"issue":"1","key":"4303_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13287-024-03722-3","volume":"15","author":"G Maged","year":"2024","unstructured":"Maged G, Abdelsamed MA, Wang H, Lotfy A. The potency of mesenchymal stem\/stromal cells: does donor sex matter? Stem Cell Res Ther. 2024;15(1):112.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4303_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13287-019-1287-9","volume":"10","author":"L Zhao","year":"2019","unstructured":"Zhao L, Chen S, Yang P, Cao H, Li L. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease. Stem Cell Res Ther. 2019;10(1):182.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4303_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13287-023-03518-x","volume":"14","author":"W Lu","year":"2023","unstructured":"Lu W, Qu J, Yan L, Tang X, Wang X, Ye A, et al. Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis. Stem Cell Res Ther. 2023;14(1):301.","journal-title":"Stem Cell Res Ther"},{"key":"4303_CR27","doi-asserted-by":"crossref","unstructured":"Lootens T, Roman BI, Stevens CV, De Wever O, Raedt R. Glioblastoma-associated mesenchymal stem\/stromal cells and cancer-associated fibroblasts: partners in crime? Int J Mol Sci. 2024;25(4).","DOI":"10.3390\/ijms25042285"},{"issue":"1","key":"4303_CR28","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1038\/s41598-024-55103-8","volume":"14","author":"H Guo","year":"2024","unstructured":"Guo H, Liu Y, Yu X, Tian N, Liu Y, Yu D. Identifying key antioxidative stress factors regulating Nrf2 in the genioglossus with human umbilical cord mesenchymal stem-cell therapy. Sci Rep. 2024;14(1):5838.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"4303_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.07.013","volume":"227","author":"B Yamout","year":"2010","unstructured":"Yamout B, Hourani R, Salti H, Barada W, El-Hajj T, Al-Kutoubi A, et al. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J Neuroimmunol. 2010;227(1\u20132):185\u20139.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"4303_CR30","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/ard.2009.123463","volume":"69","author":"J Liang","year":"2010","unstructured":"Liang J, Zhang H, Hua B, Wang H, Lu L, Shi S, et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis. 2010;69(8):1423\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4303_CR31","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","volume":"48","author":"D Garc\u00eda-Olmo","year":"2005","unstructured":"Garc\u00eda-Olmo D, Garc\u00eda-Arranz M, Herreros D, Pascual I, Peiro C, Rodr\u00edguez-Montes JA. A phase I clinical trial of the treatment of Crohn\u2019s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005;48(7):1416\u201323.","journal-title":"Dis Colon Rectum"},{"issue":"19","key":"4303_CR32","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1161\/01.CIR.0000167553.49133.81","volume":"111","author":"TS Li","year":"2005","unstructured":"Li TS, Hayashi M, Ito H, Furutani A, Murata T, Matsuzaki M, Hamano K. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation. 2005;111(19):2438\u201345.","journal-title":"Circulation"},{"issue":"3","key":"4303_CR33","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbrc.2007.01.045","volume":"354","author":"Y Iso","year":"2007","unstructured":"Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, Song YH, Sobel BE, Delafontaine P, Prockop DJ. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun. 2007;354(3):700\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"46","key":"4303_CR34","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1073\/pnas.0608249103","volume":"103","author":"RH Lee","year":"2006","unstructured":"Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, Prockop DJ. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice. Proc Natl Acad Sci U S A. 2006;103(46):17438\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4303_CR35","doi-asserted-by":"publisher","first-page":"897398","DOI":"10.3389\/fped.2022.897398","volume":"10","author":"J Qu","year":"2022","unstructured":"Qu J, Liu Z, Li L, Zou Z, He Z, Zhou L, Luo Y, Zhang M, Ye J. Efficacy and safety of stem cell therapy in children with autism spectrum disorders: a systematic review and meta-analysis. Front Pediatr. 2022;10:897398.","journal-title":"Front Pediatr"},{"issue":"Pt 8","key":"4303_CR36","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1242\/jcs.076935","volume":"124","author":"J Veevers-Lowe","year":"2011","unstructured":"Veevers-Lowe J, Ball SG, Shuttleworth A, Kielty CM. Mesenchymal stem cell migration is regulated by fibronectin through \u03b15\u03b21-integrin-mediated activation of PDGFR-\u03b2 and potentiation of growth factor signals. J Cell Sci. 2011;124(Pt 8):1288\u2013300.","journal-title":"J Cell Sci"},{"issue":"6","key":"4303_CR37","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bbmt.2010.01.011","volume":"16","author":"F Baron","year":"2010","unstructured":"Baron F, Lechanteur C, Willems E, Bruck F, Baudoux E, Seidel L, et al. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biol Blood Marrow Transpl. 2010;16(6):838\u201347.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"4303_CR38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/bmt.2008.348","volume":"43","author":"ML Macmillan","year":"2009","unstructured":"Macmillan ML, Blazar BR, DeFor TE, Wagner JE. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transpl. 2009;43(6):447\u201354.","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"4303_CR39","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/SLA.0000000000001155","volume":"263","author":"HM Tautenhahn","year":"2016","unstructured":"Tautenhahn HM, Br\u00fcckner S, Baumann S, Winkler S, Otto W, von Bergen M, Bartels M, Christ B. Attenuation of postoperative acute liver failure by mesenchymal stem cell treatment due to metabolic implications. Ann Surg. 2016;263(3):546\u201356.","journal-title":"Ann Surg"},{"issue":"6","key":"4303_CR40","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s12015-016-9683-3","volume":"12","author":"YH Li","year":"2016","unstructured":"Li YH, Xu Y, Wu HM, Yang J, Yang LH, Yue-Meng W. Umbilical cord-derived mesenchymal stem cell transplantation in hepatitis B virus related acute-on-chronic liver failure treated with plasma exchange and entecavir: a 24-month prospective study. Stem Cell Rev Rep. 2016;12(6):645\u201353.","journal-title":"Stem Cell Rev Rep"},{"key":"4303_CR41","doi-asserted-by":"crossref","unstructured":"Schacher FC, Martins Pezzi da Silva A, Silla L, \u00c1lvares-da-Silva MR. Bone marrow mesenchymal stem cells in acute-on-chronic liver failure grades 2 and 3: a phase I-II randomized clinical trial. Can J Gastroenterol Hepatol. 2021;2021:3662776.","DOI":"10.1155\/2021\/3662776"},{"issue":"3","key":"4303_CR42","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/hep.24434","volume":"54","author":"L Peng","year":"2011","unstructured":"Peng L, Xie DY, Lin BL, Liu J, Zhu HP, Xie C, Zheng YB, Gao ZL. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology. 2011;54(3):820\u20138.","journal-title":"Hepatology"},{"issue":"10","key":"4303_CR43","doi-asserted-by":"publisher","first-page":"725","DOI":"10.5966\/sctm.2012-0034","volume":"1","author":"M Shi","year":"2012","unstructured":"Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med. 2012;1(10):725\u201331.","journal-title":"Stem Cells Transl Med"},{"key":"4303_CR44","doi-asserted-by":"crossref","unstructured":"Xu WX, He HL, Pan SW, Chen YL, Zhang ML, Zhu S, Gao ZL, Peng L, Li JG. Combination treatments of plasma exchange and umbilical cord-derived mesenchymal stem cell transplantation for patients with hepatitis B virus-related acute-on-chronic liver failure: a clinical trial in China. Stem Cells Int. 2019;2019:4130757.","DOI":"10.1155\/2019\/4130757"},{"issue":"1","key":"4303_CR45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.29189","volume":"66","author":"BL Lin","year":"2017","unstructured":"Lin BL, Chen JF, Qiu WH, Wang KW, Xie DY, Chen XY, et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial. Hepatology. 2017;66(1):209\u201319.","journal-title":"Hepatology"},{"issue":"1","key":"4303_CR46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13287-022-02882-4","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Dong Y, Wu X, Xu X, Niu J. The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials. Stem Cell Res Ther. 2022;13(1):204.","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"4303_CR47","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1097\/MEG.0000000000001156","volume":"30","author":"B Chen","year":"2018","unstructured":"Chen B, Wang YH, Qian JQ, Wu DB, Chen EQ, Tang H. Human mesenchymal stem cells for hepatitis B virus-related acute-on-chronic liver failure: a systematic review with meta-analysis. Eur J Gastroenterol Hepatol. 2018;30(10):1224\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"4303_CR48","doi-asserted-by":"publisher","first-page":"834","DOI":"10.2174\/1574888X18666221214123844","volume":"18","author":"F Cheng","year":"2023","unstructured":"Cheng F, Huang Z, Wei W, Li Z. Mesenchymal stem cell transplantation for hepatitis B virus-related acute-on-chronic liver failure: a systematic review and meta-analysis. Curr Stem Cell Res Ther. 2023;18(6):834\u201342.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"1","key":"4303_CR49","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13287-023-03494-2","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Yao W, Wang Y, Dong H, Dong T, Zhou W, et al. Meta-analysis on last ten years of clinical injection of bone marrow-derived and umbilical cord MSC to reverse cirrhosis or rescue patients with acute-on-chronic liver failure. Stem Cell Res Ther. 2023;14(1):267.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4303_CR50","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13287-020-01787-4","volume":"11","author":"Y Jia","year":"2020","unstructured":"Jia Y, Shu X, Yang X, Sun H, Cao H, Cao H, et al. Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis. Stem Cell Res Ther. 2020;11(1):277.","journal-title":"Stem Cell Res Ther"},{"key":"4303_CR51","doi-asserted-by":"publisher","first-page":"752875","DOI":"10.3389\/fmed.2021.752875","volume":"8","author":"A Khanam","year":"2021","unstructured":"Khanam A, Kottilil S. Acute-on-chronic liver failure: pathophysiological mechanisms and management. Front Med (Lausanne). 2021;8:752875.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"4303_CR52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/gutjnl-2020-322161","volume":"71","author":"G Mezzano","year":"2022","unstructured":"Mezzano G, Juanola A, Cardenas A, Mezey E, Hamilton JP, Pose E, et al. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut. 2022;71(1):148\u201355.","journal-title":"Gut"},{"issue":"2","key":"4303_CR53","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3748\/wjg.v26.i2.219","volume":"26","author":"EX Tan","year":"2020","unstructured":"Tan EX, Wang MX, Pang J, Lee GH. Plasma exchange in patients with acute and acute-on-chronic liver failure: a systematic review. World J Gastroenterol. 2020;26(2):219\u201345.","journal-title":"World J Gastroenterol"},{"key":"4303_CR54","doi-asserted-by":"crossref","unstructured":"Cuadra B, Silva V, Huang YL, Diaz Y, Rivas C, Molina C et al. The immunoregulatory and regenerative potential of activated human stem cell secretome mitigates acute-on-chronic liver failure in a rat model. Int J Mol Sci. 2024;25(4).","DOI":"10.3390\/ijms25042073"},{"issue":"1","key":"4303_CR55","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13287-021-02468-6","volume":"12","author":"Y He","year":"2021","unstructured":"He Y, Guo X, Lan T, Xia J, Wang J, Li B, et al. Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1\/Stat3 signaling. Stem Cell Res Ther. 2021;12(1):396.","journal-title":"Stem Cell Res Ther"},{"issue":"10201","key":"4303_CR56","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0140-6736(19)31894-X","volume":"394","author":"RT Stravitz","year":"2019","unstructured":"Stravitz RT, Lee WM. Acute liver failure. Lancet. 2019;394(10201):869\u201381.","journal-title":"Lancet"},{"issue":"4","key":"4303_CR57","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/hep.30056","volume":"68","author":"JS Bajaj","year":"2018","unstructured":"Bajaj JS, Moreau R, Kamath PS, Vargas HE, Arroyo V, Reddy KR, et al. Acute-on-chronic liver failure: getting ready for prime time?? Hepatology. 2018;68(4):1621\u201332.","journal-title":"Hepatology"},{"issue":"8","key":"4303_CR58","doi-asserted-by":"publisher","first-page":"562","DOI":"10.21037\/atm.2020.02.119","volume":"8","author":"Y Cao","year":"2020","unstructured":"Cao Y, Ji C, Lu L. Mesenchymal stem cell therapy for liver fibrosis\/cirrhosis. Ann Transl Med. 2020;8(8):562.","journal-title":"Ann Transl Med"},{"issue":"9","key":"4303_CR59","doi-asserted-by":"publisher","first-page":"17986","DOI":"10.3390\/ijms140917986","volume":"14","author":"HJ Jin","year":"2013","unstructured":"Jin HJ, Bae YK, Kim M, Kwon SJ, Jeon HB, Choi SJ, et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci. 2013;14(9):17986\u20138001.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"4303_CR60","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1089\/scd.2013.0477","volume":"23","author":"S Diederichs","year":"2014","unstructured":"Diederichs S, Tuan RS. Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. Stem Cells Dev. 2014;23(14):1594\u2013610.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"4303_CR61","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1038\/s41598-018-23396-1","volume":"8","author":"M Wu","year":"2018","unstructured":"Wu M, Zhang R, Zou Q, Chen Y, Zhou M, Li X, Ran R, Chen Q. Comparison of the biological characteristics of mesenchymal stem cells derived from the human placenta and umbilical cord. Sci Rep. 2018;8(1):5014.","journal-title":"Sci Rep"},{"issue":"7","key":"4303_CR62","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1359\/jbmr.1999.14.7.1115","volume":"14","author":"G D\u2019Ippolito","year":"1999","unstructured":"D\u2019Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Min Res. 1999;14(7):1115\u201322.","journal-title":"J Bone Min Res"},{"issue":"1","key":"4303_CR63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13287-019-1310-1","volume":"10","author":"C Hu","year":"2019","unstructured":"Hu C, Zhao L, Li L. Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases. Stem Cell Res Ther. 2019;10(1):199.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"4303_CR64","doi-asserted-by":"publisher","first-page":"e24353","DOI":"10.1002\/jcla.24353","volume":"36","author":"X Liu","year":"2022","unstructured":"Liu X, Liu Y, He H, Xiang W, He C. Human adipose and synovial mesenchymal stem cells improve osteoarthritis in rats by reducing chondrocyte reactive oxygen species and inhibiting inflammatory response. J Clin Lab Anal. 2022;36(5):e24353.","journal-title":"J Clin Lab Anal"},{"issue":"Suppl 2","key":"4303_CR65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","volume":"27","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol. 2012;27(Suppl 2):112\u201320.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"4303_CR66","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1478-3231.2009.02031.x","volume":"29","author":"KH Jung","year":"2009","unstructured":"Jung KH, Shin HP, Lee S, Lim YJ, Hwang SH, Han H, Park HK, Chung JH, Yim SV. Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model. Liver Int. 2009;29(6):898\u2013909.","journal-title":"Liver Int"},{"issue":"5","key":"4303_CR67","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/lt.21715","volume":"15","author":"PC Tsai","year":"2009","unstructured":"Tsai PC, Fu TW, Chen YM, Ko TL, Chen TH, Shih YH, Hung SC, Fu YS. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton\u2019s jelly in the treatment of rat liver fibrosis. Liver Transpl. 2009;15(5):484\u201395.","journal-title":"Liver Transpl"},{"issue":"1","key":"4303_CR68","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13287-022-03001-z","volume":"13","author":"L Yao","year":"2022","unstructured":"Yao L, Hu X, Dai K, Yuan M, Liu P, Zhang Q, Jiang Y. Mesenchymal stromal cells: promising treatment for liver cirrhosis. Stem Cell Res Ther. 2022;13(1):308.","journal-title":"Stem Cell Res Ther"},{"key":"4303_CR69","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fphar.2016.00231","volume":"7","author":"A Marote","year":"2016","unstructured":"Marote A, Teixeira FG, Mendes-Pinheiro B, Salgado AJ. MSCs-derived exosomes: cell-secreted nanovesicles with regenerative potential. Front Pharmacol. 2016;7:231.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4303_CR70","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jcyt.2015.10.008","volume":"18","author":"VB Konala","year":"2016","unstructured":"Konala VB, Mamidi MK, Bhonde R, Das AK, Pochampally R, Pal R. The current landscape of the mesenchymal stromal cell secretome: a new paradigm for cell-free regeneration. Cytotherapy. 2016;18(1):13\u201324.","journal-title":"Cytotherapy"},{"issue":"6","key":"4303_CR71","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22(6):845\u201354.","journal-title":"Stem Cells Dev"},{"issue":"6","key":"4303_CR72","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1038\/emm.2017.63","volume":"49","author":"G Lou","year":"2017","unstructured":"Lou G, Chen Z, Zheng M, Liu Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017;49(6):e346.","journal-title":"Exp Mol Med"},{"key":"4303_CR73","doi-asserted-by":"crossref","unstructured":"Jiang W, Tan Y, Cai M, Zhao T, Mao F, Zhang X et al. Human umbilical cord MSC-derived exosomes suppress the development of CCl(4)-induced liver injury through antioxidant effect. Stem Cells Int. 2018;2018:6079642.","DOI":"10.1155\/2018\/6079642"},{"issue":"1","key":"4303_CR74","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13287-022-02858-4","volume":"13","author":"M Yuan","year":"2022","unstructured":"Yuan M, Hu X, Yao L, Jiang Y, Li L. Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease. Stem Cell Res Ther. 2022;13(1):179.","journal-title":"Stem Cell Res Ther"},{"issue":"23","key":"4303_CR75","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1089\/scd.2013.0142","volume":"22","author":"L Zhang","year":"2013","unstructured":"Zhang L, Li K, Liu X, Li D, Luo C, Fu B, et al. Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in rats. Stem Cells Dev. 2013;22(23):3074\u201386.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"4303_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3727\/096368911X566208","volume":"21","author":"J Puppi","year":"2012","unstructured":"Puppi J, Strom SC, Hughes RD, Bansal S, Castell JV, Dagher I, et al. Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transpl. 2012;21(1):1\u201310.","journal-title":"Cell Transpl"},{"issue":"4","key":"4303_CR77","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3727\/096368909X484707a","volume":"19","author":"AA Khan","year":"2010","unstructured":"Khan AA, Shaik MV, Parveen N, Rajendraprasad A, Aleem MA, Habeeb MA, et al. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transpl. 2010;19(4):409\u201318.","journal-title":"Cell Transpl"},{"issue":"6","key":"4303_CR78","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1499-3872(16)60141-8","volume":"15","author":"JF Sang","year":"2016","unstructured":"Sang JF, Shi XL, Han B, Huang T, Huang X, Ren HZ, Ding YT. Intraportal mesenchymal stem cell transplantation prevents acute liver failure through promoting cell proliferation and inhibiting apoptosis. Hepatobiliary Pancreat Dis Int. 2016;15(6):602\u201311.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"4303_CR79","doi-asserted-by":"publisher","first-page":"1006845","DOI":"10.3389\/fbioe.2022.1006845","volume":"10","author":"J Qu","year":"2022","unstructured":"Qu J, Zhou L, Zhang H, Han D, Luo Y, Chen J, et al. Efficacy and safety of stem cell therapy in cerebral palsy: a systematic review and meta-analysis. Front Bioeng Biotechnol. 2022;10:1006845.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"4303_CR80","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/wsbm.26","volume":"1","author":"NS Hwang","year":"2009","unstructured":"Hwang NS, Zhang C, Hwang YS, Varghese S. Mesenchymal stem cell differentiation and roles in regenerative medicine. Wiley Interdiscip Rev Syst Biol Med. 2009;1(1):97\u2013106.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"6","key":"4303_CR81","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41423-023-00983-5","volume":"20","author":"X Yang","year":"2023","unstructured":"Yang X, Li Q, Liu W, Zong C, Wei L, Shi Y, Han Z. Mesenchymal stromal cells in hepatic fibrosis\/cirrhosis: from pathogenesis to treatment. Cell Mol Immunol. 2023;20(6):583\u201399.","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"4303_CR82","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/1756-185X.13015","volume":"20","author":"J Liang","year":"2017","unstructured":"Liang J, Zhang H, Zhao C, Wang D, Ma X, Zhao S, Wang S, Niu L, Sun L. Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases. Int J Rheum Dis. 2017;20(9):1219\u201326.","journal-title":"Int J Rheum Dis"},{"key":"4303_CR83","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12967-014-0246-6","volume":"12","author":"L Wei","year":"2014","unstructured":"Wei L, Zhang J, Xiao XB, Mai HX, Zheng K, Sun WL, et al. Multiple injections of human umbilical cord-derived mesenchymal stromal cells through the tail vein improve microcirculation and the microenvironment in a rat model of radiation myelopathy. J Transl Med. 2014;12:246.","journal-title":"J Transl Med"},{"issue":"2","key":"4303_CR84","first-page":"109","volume":"6","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Xia Y, Ni S, Gu Z, Liu H. Transplantation of umbilical cord mesenchymal stem cells alleviates pneumonitis of MRL\/lpr mice. J Thorac Dis. 2014;6(2):109\u201317.","journal-title":"J Thorac Dis"},{"issue":"10","key":"4303_CR85","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.14309\/ajg.0000000000000388","volume":"114","author":"S Gawrieh","year":"2019","unstructured":"Gawrieh S, Wilson LA, Cummings OW, Clark JM, Loomba R, Hameed B, et al. Histologic findings of advanced fibrosis and cirrhosis in patients with nonalcoholic fatty liver disease who have normal aminotransferase levels. Am J Gastroenterol. 2019;114(10):1626\u201335.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"4303_CR86","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00441-012-1524-3","volume":"351","author":"X Zhu","year":"2013","unstructured":"Zhu X, He B, Zhou X, Ren J. Effects of transplanted bone-marrow-derived mesenchymal stem cells in animal models of acute hepatitis. Cell Tissue Res. 2013;351(3):477\u201386.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"4303_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04327.x","volume":"164","author":"M Shi","year":"2011","unstructured":"Shi M, Liu ZW, Wang FS. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol. 2011;164(1):1\u20138.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"4303_CR88","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/gut.2005.090050","volume":"56","author":"I Aurich","year":"2007","unstructured":"Aurich I, Mueller LP, Aurich H, Luetzkendorf J, Tisljar K, Dollinger MM, et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut. 2007;56(3):405\u201315.","journal-title":"Gut"},{"issue":"2","key":"4303_CR89","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/gut.2006.111617","volume":"57","author":"LV di Bonzo","year":"2008","unstructured":"di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, Novo E, et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut. 2008;57(2):223\u201331.","journal-title":"Gut"},{"issue":"8","key":"4303_CR90","doi-asserted-by":"publisher","first-page":"e6657","DOI":"10.1371\/journal.pone.0006657","volume":"4","author":"RM Baertschiger","year":"2009","unstructured":"Baertschiger RM, Serre-Beinier V, Morel P, Bosco D, Peyrou M, Cl\u00e9ment S, et al. Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver. PLoS ONE. 2009;4(8):e6657.","journal-title":"PLoS ONE"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04303-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04303-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04303-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T16:01:55Z","timestamp":1745164915000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04303-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,20]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4303"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04303-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,20]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"197"}}